Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL059818-03
Application #
6056503
Study Section
Special Emphasis Panel (ZHL1-CSR-F (S1))
Project Start
1997-09-30
Project End
2002-08-31
Budget Start
1999-09-01
Budget End
2000-08-31
Support Year
3
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of South Florida
Department
Biochemistry
Type
Schools of Medicine
DUNS #
City
Tampa
State
FL
Country
United States
Zip Code
33612
Cao, Chuanhai; Bai, Yun; Holloway, Mary Jolene et al. (2004) Characterization of a novel human anti-HIV-1 gp41 IgM monoclonal antibody designated clone 37. DNA Cell Biol 23:836-41
Gomez-Roman, Victor Raul; Cao, Chuanhai; Bai, Yun et al. (2002) Phage-displayed mimotopes recognizing a biologically active anti-HIV-1 gp120 murine monoclonal antibody. J Acquir Immune Defic Syndr 31:147-53
Edgeworth, R L; Ugen, K E (2000) Immunopathological factors for vertical transmission of HIV-1. Pathobiology 68:53-67
Dickey, C; Ziegner, U; Agadjanyan, M G et al. (2000) Murine monoclonal antibodies biologically active against the amino region of HIV-1 gp120: isolation and characterization. DNA Cell Biol 19:243-52
Viveros, M; Dickey, C; Cotropia, J P et al. (2000) Characterization of a novel human immunodeficiency virus type 1 neutralizable epitope within the immunodominant region of gp41. Virology 270:135-45
Bagarazzi, M L; Boyer, J D; Javadian, M A et al. (1999) Systemic and mucosal immunity is elicited after both intramuscular and intravaginal delivery of human immunodeficiency virus type 1 DNA plasmid vaccines to pregnant chimpanzees. J Infect Dis 180:1351-5
MacGregor, R R; Boyer, J D; Ugen, K E et al. (1998) First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response. J Infect Dis 178:92-100
Nyland, S B; Specter, S; Im-Sin, J et al. (1998) Opiate effects on in vitro human retroviral infection. Adv Exp Med Biol 437:91-100
Ugen, K E; Nyland, S B; Boyer, J D et al. (1998) DNA vaccination with HIV-1 expressing constructs elicits immune responses in humans. Vaccine 16:1818-21